"Adoptive Transfer" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Form of passive immunization where previously sensitized immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (IMMUNOTHERAPY, ADOPTIVE).
| Descriptor ID |
D019264
|
| MeSH Number(s) |
E02.095.465.425.400.330.050 E05.478.550.520.050
|
| Concept/Terms |
Adoptive Cell Transfer- Adoptive Cell Transfer
- Adoptive Cell Transfers
- Cell Transfer, Adoptive
- Cell Transfers, Adoptive
|
Below are MeSH descriptors whose meaning is more general than "Adoptive Transfer".
Below are MeSH descriptors whose meaning is more specific than "Adoptive Transfer".
This graph shows the total number of publications written about "Adoptive Transfer" by people in this website by year, and whether "Adoptive Transfer" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 4 | 4 |
| 2000 | 0 | 2 | 2 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 2 | 5 |
| 2004 | 2 | 3 | 5 |
| 2005 | 1 | 3 | 4 |
| 2006 | 1 | 3 | 4 |
| 2007 | 1 | 5 | 6 |
| 2008 | 2 | 3 | 5 |
| 2009 | 4 | 6 | 10 |
| 2010 | 2 | 3 | 5 |
| 2011 | 2 | 4 | 6 |
| 2012 | 0 | 4 | 4 |
| 2013 | 4 | 8 | 12 |
| 2014 | 0 | 12 | 12 |
| 2015 | 3 | 3 | 6 |
| 2016 | 3 | 1 | 4 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 3 | 5 |
| 2019 | 3 | 3 | 6 |
| 2020 | 0 | 2 | 2 |
| 2021 | 2 | 2 | 4 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adoptive Transfer" by people in Profiles.
-
Protection of Quiescence and Longevity of IgG Memory B Cells by Mitochondrial Autophagy. J Immunol. 2022 03 01; 208(5):1085-1098.
-
Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production. Sci Transl Med. 2021 02 03; 13(579).
-
"Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients. Blood Adv. 2019 09 10; 3(17):2571-2580.
-
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017 04 13; 544(7649):250-254.
-
Cardiovascular Toxicities Associated with Cancer Immunotherapies. Curr Cardiol Rep. 2017 03; 19(3):21.
-
Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016 07 01; 126(7):2588-96.
-
Novel Treatments in Development for Melanoma. Cancer Treat Res. 2016; 167:371-416.
-
T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi. J Exp Med. 2015 Jul 27; 212(8):1323-36.
-
TCR affinity and tolerance mechanisms converge to shape T cell diabetogenic potential. J Immunol. 2014 Jul 15; 193(2):571-9.
-
Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies. Clin Cancer Res. 2014 Nov 15; 20(22):5708-19.